Search

Author/Creator Longman, Randy S

1. 494. Enteric bacteria are immune-reactive in patients with Crohn's disease with extraintestinal manifestations. (15th December 2022)

Authors:
Maldarelli, Grace A; Metz, Maeva; Funez-dePagnier, Gabriela; Lavergne, Alexa; Lai, Daniel; Chang, Adrienne; Malik, Fardina; de Vlaminck, Iwijn; Longman, Randy S
Journal:
Open forum infectious diseases
Issue:
Volume 9:(2022)Supplement 2
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. P075 MICROBIAL INDUCTION OF TL1A LINKS PROTECTIVE AND PATHOGENIC ROLES FOR GROUP 3 INNATE LYMPHOID CELLS IN COLITIS. (18th January 2018)

Authors:
Castellanos, Jim G; Woo, Viola; Viladomiu, Monica; Putzel, Gregory; Diehl, Gretchen; Scherl, Ellen; Targan, Stephan R; Shih, David Q; Longman, Randy S
Journal:
Inflammatory bowel diseases
Issue:
Volume 24(2018)Supplement 1
Page Start:
S27
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Patient-Preferences Favoring Treatment Discontinuation Are Reduced With Vedolizumab and Ustekinumab Compared With TNF Antagonists in Inflammatory Bowel Disease. Issue 4 (29th September 2020)

Authors:
Kumar, Anand; Kim, Emilie S; Kozan, Philip; Jacob, Vinita; Longman, Randy S; Scherl, Ellen J; Battat, Robert J; Lukin, Dana J
Journal:
Crohn's & colitis 360
Issue:
Volume 2:Issue 4(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗